Evidence map›Paper›PMID 30267301›Full record

ArticleExtremophiles : life under extreme conditions2019

A highly efficient and cost-effective recombinant production of a bacterial photolyase from the Antarctic isolate Hymenobacter sp. UV11.

Juan José Marizcurrena, Wilner Martínez-López, Hongju Ma, Tilman Lamparter, Susana Castro-Sowinski

Abstract read
PubMed Publisher
In one paragraph

Article in Extremophiles : life under extreme conditions, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Photolyase Production and Current Applications: A Review.Molecules (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Juan José MarizcurrenaBiochemistry and Molecular Biology, Faculty of Sciences, Universidad de la República (UdelaR), Iguá 4225, 11400, Montevideo, Uruguay.
Wilner Martínez-LópezEpigenetics and Genomics Instability Laboratory, Institute Clemente Estable, Av. Italia 3318, 11600, Montevideo, Uruguay.
Hongju MaBotanical Institute, Karlsruhe Institute for Technology, Fritz Haber Weg 4, 76131, Karlsruhe, Germany.
Tilman LamparterBotanical Institute, Karlsruhe Institute for Technology, Fritz Haber Weg 4, 76131, Karlsruhe, Germany.
Susana Castro-SowinskiBiochemistry and Molecular Biology, Faculty of Sciences, Universidad de la República (UdelaR), Iguá 4225, 11400, Montevideo, Uruguay. s.castro.sow@gmail.com.
Instituto de Investigaciones Biológicas Clemente Estable · UYKarlsruhe Institute of Technology · DEUniversidad de la República · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photolyases are DNA-repairing flavoproteins that are represented in most phylogenetic taxa with the exception of placental mammals. These enzymes reduce the ultraviolet-induced DNA damage; thus, they have features that make them very attractive for dermatological or other medical uses, such as the prevention of human skin cancer and actinic keratosis. In this work, we identified a 50.8 kDa photolyase from the UVC-resistant Antarctic bacterium Hymenobacter sp. UV11. The enzyme was produced by recombinant DNA technology, purified using immobilized metal affinity chromatography and its activity was analyzed using different approaches: detection of cyclobutane pyrimidine dimers (CPDs) by immunochemistry, high-performance liquid chromatography and comet assays using Chinese Hamster Ovary (CHO) and immortalized nontumorigenic human epidermal (HaCat) cells. The information supports that the recombinant protein has the ability to repair the formation of CPDs, on both double- and single-stranded DNA. This CPD-photolyase was fully active on CHO and HaCat cell lines, suggesting that this enzyme could be used for medical or cosmetic purposes. Results also suggest that the UV11 CPD-photolyase uses MTHF as chromophore in the antenna domain. The potential use of this recombinant enzyme in the development of new inventions with pharmaceutical and cosmetic applications is discussed during this work.

Indexed as

AnimalsBacterial ProteinsCHO CellsCosts and Cost AnalysisCricetinaeCricetulusDeoxyribodipyrimidine Photo-LyaseFlavobacteriaceaeHumansIndustrial MicrobiologyRecombinant ProteinsBacterial ProteinsDeoxyribodipyrimidine Photo-LyaseRecombinant ProteinsAntarcticaHymenobacterPhotolyasePhotorepairUV-irradiation

Identifiers

PMID30267301
OpenAlexW2893960712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.